Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person SLC5A2 (also known as SGLT2) in the plasma membrane co-trans...
| Class:Id | Summation:189198 |
|---|---|
| _displayName | SLC5A2 (also known as SGLT2) in the plasma membrane co-trans... |
| _timestamp | 2017-03-09 20:04:28 |
| created | [InstanceEdit:189226] D'Eustachio, P, 2006-11-04 20:44:47 |
| modified | [InstanceEdit:8981519] D'Eustachio, Peter, 2017-03-09 |
| text | SLC5A2 (also known as SGLT2) in the plasma membrane co-transports extracellular sodium ions (Na+) and glucose (Glc) into the cytosol (Quick et al. 2003; Wright 2001). SLC5A2 is expressed at high levels in the kidney (Tazawa et al. 2005) and appears to be the major mediator of kidney glucose reabsorption. Human patients who lack functional SLC5A2 (e.g., Calado et al. 2004) and mouse strains lacking its homolog (Vallon et al. 2011) excrete abnormally large amounts of glucose in the urine but exhibit normal uptake of dietary glucose. |
| (summation) | [Reaction:189208] SLC5A2 cotransports Na+ and glucose from extracellular region to cytosol [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by SLC5A2 (also known as SGLT2) in the plasma membrane co-trans... (189198)
